Table 1 Baseline characteristics of the study population.

From: Identification of two novel genes SLC15A2 and SLCO1B3 associated with maintenance dose variability of warfarin in a Chinese population

Demographic characteristics

Patients

Age (years)

52.8 ± 11.8

Gender [n (%)]

 Male

85 (42.3%)

 Female

116 (57.7%)

 Weight (kg)

60.5 ± 10.9

 Height (cm)

162.6 ± 7.3

 Combination use of amiodarone [n (%)]

5 (2.5%)

 Combination use of enzyme inhibitor [n (%)]

18 (9.0%)

 Stable warfarin dose (mg/day)

3.14 ± 1.41

Indications [n (%)]

 Atrial fibrillation

31 (15.4%)

 Heart valve replacement#

162 (80.6%)

 Deep vein thrombosis

8 (4%)

  1. #Twelve patients have heart valve replacement with atrial fibrillation, 1 patient has heart valve replacement with deep vein thrombosis.